HEADER OXIDOREDUCTASE 20-FEB-18 6CGE TITLE CRYSTAL STRUCTURE OF HUMAN 17BETA-HSD TYPE 1 IN TERNARY COMPLEX WITH TITLE 2 PBRM AND NADP+ COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTRADIOL 17-BETA-DEHYDROGENASE 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 17-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1,17-BETA-HSD 1,20 COMPND 5 ALPHA-HYDROXYSTEROID DEHYDROGENASE,20-ALPHA-HSD,E2DH,PLACENTAL 17- COMPND 6 BETA-HYDROXYSTEROID DEHYDROGENASE,SHORT CHAIN DEHYDROGENASE/REDUCTASE COMPND 7 FAMILY 28C MEMBER 1; COMPND 8 EC: 1.1.1.62; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HSD17B1, E17KSR, EDH17B1, EDH17B2, EDHB17, SDR28C1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1711 KEYWDS INHIBITOR, COMPLEX, HYDROXYSTEROID DEHYDROGENASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR T.LI,S.X.LIN REVDAT 3 23-OCT-24 6CGE 1 REMARK REVDAT 2 04-OCT-23 6CGE 1 REMARK REVDAT 1 16-JAN-19 6CGE 0 JRNL AUTH T.LI,R.MALTAIS,D.POIRIER,S.X.LIN JRNL TITL COMBINED BIOPHYSICAL CHEMISTRY REVEALS A NEW COVALENT JRNL TITL 2 INHIBITOR WITH A LOW-REACTIVITY ALKYL HALIDE. JRNL REF J PHYS CHEM LETT V. 9 5275 2018 JRNL REFN ESSN 1948-7185 JRNL PMID 30148957 JRNL DOI 10.1021/ACS.JPCLETT.8B02225 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 26858 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.303 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1459 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1907 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.23 REMARK 3 BIN R VALUE (WORKING SET) : 0.3090 REMARK 3 BIN FREE R VALUE SET COUNT : 108 REMARK 3 BIN FREE R VALUE : 0.3430 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4247 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 124 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.39000 REMARK 3 B22 (A**2) : -3.48000 REMARK 3 B33 (A**2) : 2.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.344 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.275 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.228 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.442 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.892 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4462 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 4329 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6076 ; 1.663 ; 2.020 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9918 ; 1.006 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 552 ; 6.563 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 179 ;33.751 ;22.235 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 717 ;16.010 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;17.485 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 710 ; 0.083 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4930 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1014 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 6CGE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1000232715. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5-7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : KOHZU HLD-4 DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.2.0 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.22 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28372 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 24.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09900 REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 6.10 REMARK 200 R MERGE FOR SHELL (I) : 0.47700 REMARK 200 R SYM FOR SHELL (I) : 0.47700 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP 11.4.05 REMARK 200 STARTING MODEL: 1JTV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.57 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.94 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, POTASSIUM PHOSPHATE REMARK 280 MONOBASIC, EVAPORATION, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.41000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 58.18000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.47000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 58.18000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.41000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.47000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7060 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 191 REMARK 465 PHE A 192 REMARK 465 MET A 193 REMARK 465 GLU A 194 REMARK 465 LYS A 195 REMARK 465 VAL A 196 REMARK 465 ASP A 286 REMARK 465 VAL A 287 REMARK 465 PRO A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 ALA A 291 REMARK 465 GLU A 292 REMARK 465 ALA A 293 REMARK 465 GLY A 294 REMARK 465 ALA A 295 REMARK 465 GLU A 296 REMARK 465 ALA A 297 REMARK 465 GLY A 298 REMARK 465 GLY A 299 REMARK 465 GLY A 300 REMARK 465 ALA A 301 REMARK 465 GLY A 302 REMARK 465 PRO A 303 REMARK 465 GLY A 304 REMARK 465 ALA A 305 REMARK 465 GLU A 306 REMARK 465 ASP A 307 REMARK 465 GLU A 308 REMARK 465 ALA A 309 REMARK 465 GLY A 310 REMARK 465 ARG A 311 REMARK 465 GLY A 312 REMARK 465 ALA A 313 REMARK 465 VAL A 314 REMARK 465 GLY A 315 REMARK 465 ASP A 316 REMARK 465 PRO A 317 REMARK 465 GLU A 318 REMARK 465 LEU A 319 REMARK 465 GLY A 320 REMARK 465 ASP A 321 REMARK 465 PRO A 322 REMARK 465 PRO A 323 REMARK 465 ALA A 324 REMARK 465 ALA A 325 REMARK 465 PRO A 326 REMARK 465 GLN A 327 REMARK 465 MET B 0 REMARK 465 ALA B 191 REMARK 465 PHE B 192 REMARK 465 MET B 193 REMARK 465 GLU B 194 REMARK 465 LYS B 195 REMARK 465 VAL B 196 REMARK 465 LEU B 197 REMARK 465 GLY B 198 REMARK 465 ASP B 286 REMARK 465 VAL B 287 REMARK 465 PRO B 288 REMARK 465 ALA B 289 REMARK 465 LYS B 290 REMARK 465 ALA B 291 REMARK 465 GLU B 292 REMARK 465 ALA B 293 REMARK 465 GLY B 294 REMARK 465 ALA B 295 REMARK 465 GLU B 296 REMARK 465 ALA B 297 REMARK 465 GLY B 298 REMARK 465 GLY B 299 REMARK 465 GLY B 300 REMARK 465 ALA B 301 REMARK 465 GLY B 302 REMARK 465 PRO B 303 REMARK 465 GLY B 304 REMARK 465 ALA B 305 REMARK 465 GLU B 306 REMARK 465 ASP B 307 REMARK 465 GLU B 308 REMARK 465 ALA B 309 REMARK 465 GLY B 310 REMARK 465 ARG B 311 REMARK 465 GLY B 312 REMARK 465 ALA B 313 REMARK 465 VAL B 314 REMARK 465 GLY B 315 REMARK 465 ASP B 316 REMARK 465 PRO B 317 REMARK 465 GLU B 318 REMARK 465 LEU B 319 REMARK 465 GLY B 320 REMARK 465 ASP B 321 REMARK 465 PRO B 322 REMARK 465 PRO B 323 REMARK 465 ALA B 324 REMARK 465 ALA B 325 REMARK 465 PRO B 326 REMARK 465 GLN B 327 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 213 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 245 NE - CZ - NH2 ANGL. DEV. = 3.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 115 -62.56 -105.89 REMARK 500 THR A 140 95.03 -69.19 REMARK 500 PHE A 151 -6.24 66.10 REMARK 500 PRO A 200 -78.77 -118.73 REMARK 500 ALA A 229 12.78 -149.01 REMARK 500 ALA A 230 90.65 -69.79 REMARK 500 ARG A 258 -7.82 -46.85 REMARK 500 ALA B 53 56.25 39.52 REMARK 500 VAL B 115 -60.72 -101.86 REMARK 500 ASP B 208 156.20 -42.27 REMARK 500 PHE B 284 50.14 -103.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAP A 401 REMARK 610 NAP B 401 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue F0D A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NAP B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide F0D B 402 and HIS B REMARK 800 221 DBREF 6CGE A 0 327 UNP P14061 DHB1_HUMAN 1 328 DBREF 6CGE B 0 327 UNP P14061 DHB1_HUMAN 1 328 SEQRES 1 A 328 MET ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER SEQRES 2 A 328 GLY ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP SEQRES 3 A 328 PRO SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP SEQRES 4 A 328 LEU LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA SEQRES 5 A 328 LEU ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU SEQRES 6 A 328 ASP VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU SEQRES 7 A 328 ARG VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN SEQRES 8 A 328 ALA GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY SEQRES 9 A 328 GLU ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL SEQRES 10 A 328 GLY THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET SEQRES 11 A 328 LYS ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER SEQRES 12 A 328 VAL GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR SEQRES 13 A 328 CYS ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER SEQRES 14 A 328 LEU ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER SEQRES 15 A 328 LEU ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU SEQRES 16 A 328 LYS VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR SEQRES 17 A 328 ASP ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA SEQRES 18 A 328 HIS SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO SEQRES 19 A 328 GLU GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA SEQRES 20 A 328 PRO LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE SEQRES 21 A 328 LEU PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SEQRES 22 A 328 SER ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY SEQRES 23 A 328 ASP VAL PRO ALA LYS ALA GLU ALA GLY ALA GLU ALA GLY SEQRES 24 A 328 GLY GLY ALA GLY PRO GLY ALA GLU ASP GLU ALA GLY ARG SEQRES 25 A 328 GLY ALA VAL GLY ASP PRO GLU LEU GLY ASP PRO PRO ALA SEQRES 26 A 328 ALA PRO GLN SEQRES 1 B 328 MET ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER SEQRES 2 B 328 GLY ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP SEQRES 3 B 328 PRO SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP SEQRES 4 B 328 LEU LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA SEQRES 5 B 328 LEU ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU SEQRES 6 B 328 ASP VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU SEQRES 7 B 328 ARG VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN SEQRES 8 B 328 ALA GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY SEQRES 9 B 328 GLU ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL SEQRES 10 B 328 GLY THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET SEQRES 11 B 328 LYS ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER SEQRES 12 B 328 VAL GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR SEQRES 13 B 328 CYS ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER SEQRES 14 B 328 LEU ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER SEQRES 15 B 328 LEU ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU SEQRES 16 B 328 LYS VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR SEQRES 17 B 328 ASP ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA SEQRES 18 B 328 HIS SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO SEQRES 19 B 328 GLU GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA SEQRES 20 B 328 PRO LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE SEQRES 21 B 328 LEU PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SEQRES 22 B 328 SER ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY SEQRES 23 B 328 ASP VAL PRO ALA LYS ALA GLU ALA GLY ALA GLU ALA GLY SEQRES 24 B 328 GLY GLY ALA GLY PRO GLY ALA GLU ASP GLU ALA GLY ARG SEQRES 25 B 328 GLY ALA VAL GLY ASP PRO GLU LEU GLY ASP PRO PRO ALA SEQRES 26 B 328 ALA PRO GLN HET NAP A 401 31 HET F0D A 402 31 HET NAP B 401 31 HET F0D B 402 31 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM F0D 3-{[(14BETA,16ALPHA,17ALPHA)-3-(2-BROMOETHYL)-17- HETNAM 2 F0D HYDROXYESTRA-1,3,5(10)-TRIEN-16-YL]METHYL}BENZAMIDE HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 3 NAP 2(C21 H28 N7 O17 P3) FORMUL 4 F0D 2(C28 H34 BR N O2) FORMUL 7 HOH *27(H2 O) HELIX 1 AA1 SER A 12 SER A 24 1 13 HELIX 2 AA2 ASP A 38 THR A 41 5 4 HELIX 3 AA3 GLN A 42 LEU A 52 1 11 HELIX 4 AA4 ASP A 68 ARG A 78 1 11 HELIX 5 AA5 PRO A 98 LEU A 102 5 5 HELIX 6 AA6 GLY A 103 VAL A 115 1 13 HELIX 7 AA7 VAL A 115 GLY A 133 1 19 HELIX 8 AA8 GLY A 144 LEU A 146 5 3 HELIX 9 AA9 ASN A 152 LEU A 173 1 22 HELIX 10 AB1 LEU A 174 PHE A 176 5 3 HELIX 11 AB2 PRO A 200 THR A 207 1 8 HELIX 12 AB3 ASP A 208 ALA A 230 1 23 HELIX 13 AB4 ASN A 232 ALA A 246 1 15 HELIX 14 AB5 PHE A 259 LEU A 267 1 9 HELIX 15 AB6 GLY A 272 PHE A 284 1 13 HELIX 16 AB7 SER B 12 ASP B 25 1 14 HELIX 17 AB8 ASP B 38 THR B 41 5 4 HELIX 18 AB9 GLN B 42 LEU B 52 1 11 HELIX 19 AC1 ASP B 68 ARG B 78 1 11 HELIX 20 AC2 PRO B 98 LEU B 102 5 5 HELIX 21 AC3 GLY B 103 VAL B 115 1 13 HELIX 22 AC4 VAL B 115 GLY B 133 1 19 HELIX 23 AC5 GLY B 144 LEU B 146 5 3 HELIX 24 AC6 ASN B 152 LEU B 174 1 23 HELIX 25 AC7 PRO B 200 ARG B 206 1 7 HELIX 26 AC8 ASP B 208 ALA B 230 1 23 HELIX 27 AC9 ASN B 232 ALA B 246 1 15 HELIX 28 AD1 PHE B 259 ASP B 269 1 11 HELIX 29 AD2 GLY B 272 PHE B 284 1 13 SHEET 1 AA1 7 LEU A 59 GLN A 63 0 SHEET 2 AA1 7 PHE A 30 LEU A 36 1 N ALA A 34 O GLU A 60 SHEET 3 AA1 7 THR A 3 ILE A 7 1 N VAL A 5 O LYS A 31 SHEET 4 AA1 7 VAL A 86 CYS A 89 1 O VAL A 88 N LEU A 6 SHEET 5 AA1 7 GLY A 135 SER A 142 1 O LEU A 138 N LEU A 87 SHEET 6 AA1 7 VAL A 178 CYS A 185 1 O SER A 181 N VAL A 137 SHEET 7 AA1 7 ARG A 252 PHE A 254 1 O TYR A 253 N GLU A 184 SHEET 1 AA2 7 LEU B 59 GLN B 63 0 SHEET 2 AA2 7 PHE B 30 LEU B 36 1 N VAL B 32 O GLU B 60 SHEET 3 AA2 7 THR B 3 ILE B 7 1 N VAL B 5 O TYR B 33 SHEET 4 AA2 7 VAL B 86 CYS B 89 1 O VAL B 88 N LEU B 6 SHEET 5 AA2 7 GLY B 135 SER B 142 1 O LEU B 138 N LEU B 87 SHEET 6 AA2 7 VAL B 178 CYS B 185 1 O ILE B 183 N VAL B 139 SHEET 7 AA2 7 ARG B 252 PHE B 254 1 O TYR B 253 N GLU B 184 LINK NE2 HIS A 221 C31 F0D A 402 1555 1555 1.31 LINK NE2 HIS B 221 C31 F0D B 402 1555 1555 1.29 SITE 1 AC1 16 GLY A 9 SER A 11 SER A 12 GLY A 13 SITE 2 AC1 16 ILE A 14 ARG A 37 LEU A 64 ASP A 65 SITE 3 AC1 16 VAL A 66 ASN A 90 ALA A 91 GLY A 92 SITE 4 AC1 16 THR A 190 HOH A 501 HOH A 505 HOH A 512 SITE 1 AC2 16 GLY A 94 LEU A 95 SER A 142 GLY A 144 SITE 2 AC2 16 LEU A 149 ASN A 152 TYR A 155 CYS A 185 SITE 3 AC2 16 GLY A 186 PRO A 187 LEU A 197 TYR A 218 SITE 4 AC2 16 HIS A 221 SER A 222 PHE A 259 GLU A 282 SITE 1 AC3 17 GLY B 9 SER B 11 SER B 12 GLY B 13 SITE 2 AC3 17 ILE B 14 ARG B 37 LEU B 64 ASP B 65 SITE 3 AC3 17 VAL B 66 ARG B 67 ALA B 91 GLY B 92 SITE 4 AC3 17 THR B 190 HOH B 505 HOH B 509 HOH B 512 SITE 5 AC3 17 HOH B 515 SITE 1 AC4 20 GLY B 94 LEU B 95 SER B 142 VAL B 143 SITE 2 AC4 20 LEU B 149 ASN B 152 TYR B 155 CYS B 185 SITE 3 AC4 20 GLY B 186 PRO B 187 GLN B 217 TYR B 218 SITE 4 AC4 20 LEU B 219 ALA B 220 SER B 222 LYS B 223 SITE 5 AC4 20 GLN B 224 VAL B 225 GLU B 282 VAL B 283 CRYST1 42.820 108.940 116.360 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023354 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009179 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008594 0.00000